Product Details
Route Of Administration
Subcutaneous (SC)
Pack Type
Single-Dose Vial
Composition
Daratumumab 1800mg + Hyaluronidase-fihj 30,000 Units / 15ml
Usage
Used For Multiple Myeloma Treatment (as Prescribed)
Storage
Store Refrigerated At 2°C To 8°C, Protect From Light
Prescription Status
Rx / Prescription Required (as Per Local Rules)
We offer Darzalex Faspro® 1800mg Injection, a subcutaneous injection used for multiple myeloma treatment as prescribed. Each single-dose vial contains Daratumumab 1800mg + Hyaluronidase-fihj 30, manufactured by Janssen. This product is designed for easy administration and comes in a convenient pack size of 15ml. Ideal for exporters, suppliers, and traders in the healthcare industry seeking a reliable solution for their customers.